Clinical Trials in Seoul, Gwanak-gu
7 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 2
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Endometrioid Ovarian CancerFallopian Tube CancerEpithelial Ovarian Cancer+1 more
TORL Biotherapeutics, LLC230 enrolled66 locationsNCT06690775
Recruiting
Phase 1
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions
Healthy Volunteers
Daewoong Pharmaceutical Co. LTD.40 enrolled1 locationNCT07260851
Recruiting
Phase 1
Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.
Healthy Volunteers
Daewoong Pharmaceutical Co. LTD.36 enrolled1 locationNCT07267221
Recruiting
Phase 1
A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers
Dyslipidemia
Korea United Pharm. Inc.50 enrolled1 locationNCT07162441
Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)
Diabetes Mellitus
Boryung Pharmaceutical Co., Ltd52 enrolled1 locationNCT07083388
Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)
Diabete Mellitus
Boryung Pharmaceutical Co., Ltd40 enrolled1 locationNCT07083401
Recruiting
Not Applicable
Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe)
Mobile HealthDrug LabellingMedication management
Seoul National University360 enrolled1 locationNCT06703697